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The primary sequence of non-gastric H,K-ATPase differs much more between species than that of Na,K-ATPase or gastric H,K-ATPase. To
investigate whether this causes species-dependent differences in enzymatic properties, we co-expressed the catalytic subunit of human non-gastric
H,K-ATPase in Sf9 cells with the β1 subunit of rat Na,K-ATPase and compared its properties with those of the rat enzyme (Swarts et al., J. Biol.
Chem. 280, 33115–33122, 2005). Maximal ATPase activity was obtained with NH4
+ as activating cation. The enzyme was also stimulated by Na+,
but in contrast to the rat enzyme, hardly by K+. SCH 28080 inhibited the NH4
+-stimulated activity of the human enzyme much more potently than
that of the rat enzyme. The steady-state phosphorylation level of the human enzyme decreased with increasing pH, [K+], and [Na+] and nearly
doubled in the presence of oligomycin. Oligomycin increased the sensitivity of the phosphorylated intermediate to ADP, demonstrating that it
inhibited the conversion of E1P to E2P. All three cations stimulated the dephosphorylation rate dose-dependently. Our studies support a role of the
human enzyme in H+/Na+ and/or H+/NH4
+ transport but not in Na+/K+ transport.
© 2006 Elsevier B.V. All rights reserved.Keywords: H,K-ATPase; Cation-specificity; Ouabain; SCH 28080; Oligomycin1. Introduction
The non-gastric H,K-ATPase is a member of the small IIC
subfamily of P-type ATPases, which furthermore includes Na,
K-ATPase and gastric H,K-ATPase [1]. These enzymes are
characterized by their complete dependence on a β-subunit and
the fact that they transport K+ into the cell in exchange for either
Na+ or H+. The non-gastric H,K-ATPase is about equally
distant to Na,K-ATPase and gastric H,K-ATPase. In contrast to
its family members, non-gastric H,K-ATPase has no own
βQsubunit. However, immunoprecipitation and expression
studies suggest that it uses the β1-subunit of Na,K-ATPase
[2–5]. Species differences in amino acid sequence are only very
minor (1–2%) for Na,K-ATPase and gastric H,K-ATPase [6].⁎ Corresponding author. Department of Biochemistry (286), Radboud
University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen,
The Netherlands. Tel.: +31 24 3614260; fax: +31 24 3616413.
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doi:10.1016/j.bbamem.2006.10.010For non-gastric H,K-ATPase, however, these differences are
much larger (10–15%). This leaves the possibility of species-
dependent variations in kinetic properties of non-gastric H,K-
ATPase that are of physiological relevance.
At present, the physiological role of the non-gastric H,
KQATPase is unknown. The enzyme is mainly localized in colon
brush border membranes and in apical membranes of epithelial
cells located in the cortical collecting duct. The non-gastric H,
K-ATPase in distal kidney, but not colon, is upregulated in rats
put on a low K+-diet [3,7–9], suggesting its involvement in K+-
reabsorption. Its name suggests that the enzyme exchanges H+
for K+ ions. However, in a recent study we found that the
maximal ATPase activity of the rat enzyme is 3-fold higher with
NH4
+ than with K+ [5]. This might suggest that the enzyme is
involved in the reabsorption of NH4
+ rather than K+. At high
concentrations, even Na+ was able to partially activate the rat
enzyme, which would suggest a role in Na+ reabsorption.
Like the gastric H,K-ATPase, the non-gastric H,K-ATPase is
electroneutral [10]. However, ion flux measurements in rat
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transport of H+ [11]. Evidence has been provided that the
enzyme might pump, in addition to H+, Na+ out of the cell
[12,13]. However, Na+ did not affect the steady-state phosphor-
ylation level, even not at a pH of 8.5, of rat non-gastric H,
KQATPase expressed in Sf9 cells [5]. Because the enzyme
completely obeyed the Post-Albers reaction mechanism, this
finding did not support a role in outward Na+ transport.
Moreover, the apical localization of this enzyme would mean a
transport of Na+ in the luminal direction.
Another aspect of non-gastric H,K-ATPase is its sensitivity
towards the inhibitors ouabain, specific for Na,K-ATPase, and
SCH 28080, specific for gastric H,K-ATPase. Most studies
indicate that non-gastric H,K-ATPase has a very low, but
significant, sensitivity for ouabain. Thiswas confirmed for the rat
enzyme following expression in Sf9 cells [5]. The degree of
inhibition might be species dependent [14,15]. The inhibitory
effect of SCH 28080 on the Sf9 expressed rat enzyme was even
smaller [5]. The degree of inhibition by both compounds strongly
depended on the cation used to activate the enzyme. Swarts et al.
[5] also found that oligomycin inhibited the ATPase activity, but
in this case in a cation-independent fashion. Since the latter drug
is primarily known to inhibit mitochondrial ATPases it has been
used to inhibit these ATPases in an expression study with non-
gastric H,K-ATPase [16], which may explain the very low
ATPase activity measured in that particular study.
In animal studies, it is possible to determine the properties of
non-gastric H,K-ATPase in brush border membranes isolated
from colon [17]. However, a major problem with such
membranes is the presence of other transporters. In this respect,
the use of Sf9 cells has clear advantages. Moreover, Sf9 cells
allow the study of the human enzyme. This is most important
because the properties of the rat and human enzymes may be
different due to differences in primary structure. Thus results
obtained with the rat enzyme may not suffice for proper
understanding of the physiological role of non-gastric H,K-
ATPase in man. The work described in this paper shows that
there are indeed large differences in cation-dependency and
inhibitor-sensitivity between the human and the rat enzyme. Our
findings emphasize that findings obtained with the rat enzyme
should be treated with caution when transferred to the human
situation.
2. Materials and methods
2.1. Recombinant H,K-ATPase
The cDNA of the non-gastric human H,K-ATPase α2-subunit, a gift of Dr. H.
Binder [18], was cloned with BamHI behind the polyhedrin promotor in the
pFastbacDual (pFD) vector (Invitrogen, Breda, The Netherlands). The cDNA of
the non-gastric rat Na,K-ATPaseβ3-subunit (NaKβ3, also called HKcβ), a gift of
Dr. H. Binder [18], was cloned with KpnI and BamHI into the pFD vector (BbsI
and KpnI site) behind the P10 promotor. The generation of pFD vectors
containing the β1-subunit of rat Na,K-ATPase (NaKβ1) and the β-subunit of rat
gastric H,K-ATPase (HKβ) has been reported before [19,20]. Finally, the pFD-
vectors were combined to yield: pFD-HKα2, pFD-HKα2-NaKβ1, pFD-HKα2-
NaKβ3, pFD-HKα2-HKβ. All DNA manipulations were carried out according
to standard molecular biology techniques described by Sambrook et al. [21], and
the modifications were controlled by sequence analysis.2.2. Generation of recombinant viruses
The pFD vectors containing the different cDNAs were transformed to
competent DH10bac Escherichia coli cells (Invitrogen) harboring the
baculovirus genome (bacmid) and a transposition helper vector. Upon
transposition between the Tn7 sites in the transfer vector and the bacmid,
recombinant bacmids were selected and isolated [22]. Subsequently, insect Sf9
cells were transfected with recombinant bacmids using Cellfectin reagent
(Invitrogen). After a three-day incubation period, recombinant baculoviruses
were isolated and used to infect Sf9 cells at a multiplicity of infection of 0.1.
Four days after infection, the amplified viruses were harvested.
2.3. Preparation of Sf9 membranes
Sf9 cells were grown at 27 °C in 100-ml spinner flask cultures as described
by Klaassen et al. [19]. For production of H,K-ATPase, 1.5×106 cells ml−1 were
infected at a multiplicity of infection of 1–3 in the presence of 1% (v/v) ethanol
[23] and 0.1% (w/v) pluronic F-68 (ICN, Aurora, OH) in Xpress medium
(Biowittaker, Walkersville, MD) as described before [24]. After 3 days, Sf9 cells
were harvested by centrifugation at 2000×g for 5 min. The cells were washed
once at 0 °C with 0.25 M sucrose, 2 mM EDTA, and 25 mM HEPES/Tris
(pH 7.0), resuspended in sucrose/EDTA/Tris buffer and sonicated at 60 W
(Branson Power Company, Denbury, CT) for 30 s at 0 °C. After centrifugation
for 30 min at 10,000×g the supernatant was collected and recentrifuged for
60 min at 100,000×g at 4 °C. The pelleted membranes were resuspended in the
above-mentioned buffer and stored at −20 °C.
2.4. Protein determination
The protein concentrations were quantified with the modified Lowry method
according to Peterson [25] using bovine serum albumin as a standard.
2.5. Western blotting
Protein samples from the membrane fraction were solubilized in SDS-PAGE
sample buffer and separated on SDS-gels containing 10% acrylamide according
to Laemmli [26]. For immunoblotting, the separated proteins were transferred to
Immobilon polyvinylidenefluoride membranes (Millipore Corporation, Bed-
ford, MA). The expressed subunits were visualized with the antibodies Godiva,
(HKα2), 2G11 (HKβ), C385-M77 (NaKβ1) and C386-M82 (NaKβ3).
2.6. ATPase assay
The ATPase activity was determined using a radiochemical method [27]. For
this purpose, 0.6–15 μg of Sf9 membranes were added to 100 μl of medium
containing 10–2000 μM Mg-[γ-32P]-ATP, 0.8 mM MgCl2, 0.1 mM EGTA,
0.2 mM EDTA, 1 mM TrisN3, 50 mM Tris–HCl (pH 7.0) and various
concentrations of activating cations as indicated. Ionic strength was kept
constant with choline chloride. After incubation for 30 min at 37 °C, the reaction
was stopped by adding 500 μl 10% (w/v) charcoal in 6% (v/v) trichloroacetic
acid and after 10 min at 0 °C the mixture was centrifuged for 10 s at 10,000×g.
To 0.15 ml of the clear supernatant, containing the liberated inorganic phosphate
(32Pi), 3 ml OptiFluor (Canberra Packard, Tilburg, The Netherlands) was added
and the mixture was analyzed by liquid scintillation analysis. In general, blanks
were prepared by incubating in the absence of membranes. ATPase activity is
presented as the difference in activity between membranes of HKα2-expressing
cells and mock-infected cells.
2.7. ATP-dependent phosphorylation
ATP-dependent phosphorylation was determined as described before
[23,24,28]. Sf9 membranes (1–6 μg) were incubated at 0 °C or 22 °C in
50 mM Tris–acetate (pH 6.0) containing 1.3 mM MgCl2 and other ions and
drugs as indicated in a volume of 80 μl. After 30–60 min, 20 μl of 0.5 μM
[γ-32P]ATP was added and the mixture was incubated for 10 s at the same
temperature as before. The reaction was stopped by adding ice-cold 5% (w/v)
trichloroacetic acid in 0.1 M phosphoric acid and the phosphorylated protein
Fig. 1. Expression of non-gastric H,K-ATPase in Sf-9 cells. (A) Western blot
(±10 μg membranes) of the different non-gastric H,K-ATPase preparations
probed with anti-HKα2 (Godiva), anti-HKβ (2G11), anti-NaKβ1(C322-M77;
[5]) and anti-NaKβ3 (C353-M82;[5]). In lanes 6 and 7 the HKα2-NaKβ1
preparations were expressed in the presence of 0.1 and 1 μg/ml tunicamycin,
respectively. (B) ATPase activity of the membrane preparations measured in the
presence of 2.0 mM MgATP, 0.1 mM EGTA, 0.2 mM EDTA, 0.8 mM MgCl2,
1 mM TrisN3, 50 mM Tris–Acetate (pH 7.0) and 10 mM NH4Cl. Average with
S.E. of 3–9 expression experiments.
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Schuell, Dassel, Germany). After washing twice with 5 ml stop-solution, the
filters were analyzed by liquid scintillation analysis. Data are corrected for the
levels of phosphorylated protein obtained with mock-infected membranes.
2.8. Dephosphorylation studies
After ATP-dependent phosphorylation the reaction mixture was diluted from
100 μl to 500 μl with non-radioactive ATP (final concentration 1 mM; in order to
prevent rephosphorylation with radioactive ATP) in 50 mM Tris–acetate
(pH 6.0) and varying concentrations of cations or ADP as indicated. The mixture
was incubated for another 3 s at 0 °C. The reaction was stopped as described
above and the levels of phosphorylated protein were determined.
2.9. Potassium determinations
The K+ concentrations of the enzyme containing assay media, to which no
K+ was added, were determined by flame photometry (FCM 6343, Eppendorf,
Hamburg, Germany) and varied between 0.5 and 2.3 μM.
2.10. Gel electrophoresis
SDS gel electrophoresis of the phosphorylated proteins was carried out as
described before [37].
2.11. Chemicals
Cellfectin, competent DH10bac Escherichia coli cells and all enzymes
used for DNA cloning were purchased from Invitrogen. [γ-32P]ATP
(3000 Ci·mmol−1) was obtained from Amersham Biosciences, Buckingham-
shire, UK. Oligomycin was obtained from Sigma-Aldrich (Zwijndrecht, The
Netherlands). SCH 28080 was kindly provided by Dr. C.D. Strader (Schering-
Plough, Kenilworth, NJ). The antibodies Godiva and 2G11 were gifts from Drs.
M. Caplan (Yale) and J. Forte (Berkeley), respectively.
2.12. Analysis of data
All data are presented as mean values for two to five individual preparations
with standard error of the mean. Differences were tested for significance by
means of Student's t-test. IC50 and K0.5 values were determined by analyzing
the plots using the Non-Linear Curve Fitting program (Hill equation function) of
Origin 6.1 (OriginLab Corporation Northampton, MA).3. Results
3.1. Subunit expression in Sf9 cells
The α2-subunit of human non-gastric H,K-ATPase (HKα2)
was co-expressed with either the β1-subunit of rat Na,K-
ATPase (NaKβ1), the β3-subunit of rat Na,K-ATPase (NaKβ3)
or the β-subunit of rat gastric H,K-ATPase (HKβ) in Sf9 cells.
After 72 h at 27 °C, total membranes were isolated and
analyzed for proper expression of the relevant subunits. All β-
subunits were present in non-glycosylated and core-glycosy-
lated forms, as indicated by the mobilities of the various bands.
(Fig. 1A). As usual in Sf9 cells, hardly any highly glycosylated
β-subunit was found. A considerable, NH4
+-stimulated, ATPase
activity was obtained only with NaKβ1 (Fig. 1B, lane 5). With
HKβ the activity was 50-times lower, whereas with NaKβ3 the
activity was not significantly different from zero. Addition of
tunicamycin during cell growth resulted in a dose-dependent
reduction of the amount of glycosylated β-subunit accompa-nied by a similar reduction in NH4
+-stimulated ATPase activity
(Fig. 1, lanes 6 and 7).
3.2. Cation effects on the ATPase activity
In the presence of NH4
+, the ATPase activity increased dose-
dependently reaching a maximum of 41.1±2.2 μmol Pi mg
−1
protein h−1 at 10 mM NH4
+ (see Fig. 2A for a representative
experiment). The activity was half-maximal at 2 mM NH4
+.
Surprisingly, the maximal activity obtained with Na+ (100 mM)
was very high (89.2±4.0% of that with 10 mMNH4
+). However,
compared to NH4
+ about 10-times more Na+ was required for
half-maximal activation. In contrast, the maximal activity
obtained with K+ (10 mM) was only 27.2±3.2% of that with
10 mM NH4
+ and decreased upon increasing the K+ concentra-
tion to 100 mM. In the absence of added ions there was still a
significant ATPase activity above the mock background. This
activity was 11.8±1.8% of that with 10 mM NH4
+. The results
with human non-gastric H,K-ATPase markedly differ from
those previously reported for the rat enzyme, where the
maximum activities with K+ and Na+ were 60% and 20% of
that with NH4
+, respectively [5] (Table 1). The lower activity
with K+ as compared to NH4
+ was not due to the presence of
inside-out vesicles, since the activity did not increase upon
Fig. 2. Effect of various cations on the ATPase activity of HKα2-NaKβ1. The ATPase activity of the membrane preparations was measured in the presence of 2.0 mM
MgATP, 0.1 mM EGTA, 0.2 mM EDTA, 0.8 mM MgCl2, 1 mM TrisN3, at pH 7.0 (50 mM Tris–acetate buffer) at the indicated KCl (○), NaCl (▴), and NH4Cl (●)
concentrations. In panel B 10 mM KCl, in panel C 10 mM NH4Cl and in panel D 100 mM NaCl was additionally present. The ionic strength was kept constant with
choline chloride. All ATPase activities were corrected for those of mock-infected membranes.
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shown).
In order to further understand the cation effects on the
ATPase activity, we repeated the dose-activation curves in the
presence of either 10 mM KCl (Fig. 2B), 10 mM NH4Cl (Fig.
2C) or 100 mM NaCl (Fig. 2D). The figures show that the
stimulatory effects of both NH4
+ and Na+ were blocked by
relatively low concentrations of K+. In addition, Fig. 2C and D
show that the stimulatory effects of NH4
+ and Na+ were not
additive, suggesting that these cations apparently act at the same
binding site.
Despite the very low ATPase activity with HKβ we also
studied this construct in more detail because this was reported in
an earlier study [16]. Although the activities with HKβ were
only about 2% of those with NaKβ1 the relative cation
dependencies were rather similar (not shown).
Cation activation of the enzyme using NaKβ1 as accom-
panying subunit strongly depended on the concentration of ATP.
Half-maximal activities were obtained at 0.1 mM ATP (Na+),
0.4 mM ATP (NH4
+) and 1 mM ATP (K+), respectively (Fig.
3A). The ion-independent ATPase activity did not depend on
the ATP concentration.
Vanadate is a potent inhibitor of P-type ATPases provided,
however, that the enzyme is in the E2 conformation [29].
Thus, the less vanadate is needed for inhibition of theTable 1
Kinetic parameters of ATPase activity of rat and human non-gastric H,K-ATPase
Rat [5]
ATPase activity NH4
+ (10 mM) K+ (10 mM) Na+ (100
Relative activity 100%1 64.3% 18.4%
K0.5 cation 1 mM 1 mM >30 mM
K0.5 ATP 0.3 mM 0.5 mM 0.1 mM
IC50 vanadate 5 μM 1.5 μM 1.0 mM
IC50 ouabain 0.2 mM 4 mM 0.05 mM
IC50 SCH 28080 0.4 mM >5 mM 0.4 mM
IC50 oligomycin 3 μM 3 μM 3 μM
K0.5: The concentration at which 50% of the maximal activity is obtained. IC50: the con
activity. (1) absolute activity=24.0±4.0 μmol Pi mg−1 protein. h−1. (2) absolute ac
In case that the differences between the rat and human enzyme are very large the nuenzyme, the more enzyme molecules are in the E2
conformation under the given set of conditions. To determine
the sensitivity of human non-gastric H,K-ATPase for this
inhibitor, vanadate-inhibition curves were made at various
cation concentrations. Fig. 3B shows that the IC50 values for
vanadate inhibition decreased with increasing concentration
of each of the three cations, indicating an increase in
sensitivity for this inhibitor. Vanadate inhibited the ATPase
activity at maximally stimulatory concentrations of K+
(10 mM) and NH4
+ (10 mM) equally potently and much
more potently than that of Na+ (100 mM). These findings
indicate that at higher cation concentrations considerably
more enzyme is in the E2-form. When vanadate inhibition
was measured at pH 6.0 instead of pH 7.0, more vanadate
was needed to inhibit the ATPase activity (not shown). This
is in agreement with an E1-promoting effect of H
+ (see also,
Fig. 10).
3.3. Effects of Inhibitors on the ATPase activity
Fig. 4 shows the effects of ouabain (A), SCH 28080 (B) and
oligomycin (C) on the enzyme activity with either 10 mM NH4
+,
10 mM K+ or 100 mM Na+. Ouabain inhibited the Na+-
activated enzyme much more potently than the NH4
+-activated
enzyme (apparent IC50 values of 56±10 μM and 380±50 μM,Human (this study)
mM) NH4
+ (10 mM) K+ (10 mM) Na+ (100 mM)
100%2 27.2% 89.2%
2 mM 1 mM 20 mM
0.4 mM 1.2 mM 0.06 mM
1.3 μM 1.6 μM 8 μM
0.4 mM >8 mM 0.06 mM
0.03 mM >4 mM 0.02 mM
3 μM 3 μM 3 μM
centration of the inhibitor in which the activity is reduced to 50% of the maximal
tivity=41.1±2.2 μmol Pi mg−1 protein h−1.
mbers are indicated in bold.
Fig. 3. The dependence of the cation-activated ATPase activity of HKα2-NaKβ1 on ATP and vanadate. (A) ATPase activity was measured in the presence of different
MgATP concentrations as indicated, 0.1 mM EGTA, 0.2 mM EDTA, 0.8 mM MgCl2, 1 mM TrisN3, 50 mM Tris–Acetate pH 7.0 and either no added cations (□), or
100 mM NaCl (▴), or 10 mM KCl (○) or 10 mM NH4Cl (●). Ionic strength was kept constant with choline chloride. The activity in the presence of 2.5 mM ATP and
10 mM NH4
+ (= 32.1 μmol Pi. mg−1 protein h−1) was set at 100%. (B) ATPase activity was measured with various vanadate and cation concentrations with 2 mM ATP
and other additions as in panel A. At each cation concentration the IC50 value for vanadate was calculated as described under Materials and methods and plotted as
function of the cation concentration used. All ATPase activities were corrected for those of mock-infected membranes.
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NH4
+-activated enzyme almost equally potently (apparent IC50
values of 19±5 μM and 30±5 μM, respectively). Both the K+-
stimulated and the ion-independent activity were inhibited only
at very high inhibitor concentrations. Fig. 4C shows that all
activities were equally sensitive to inhibition by oligomycin
(apparent IC50 values of 3±1 μM).
3.4. ATP-phosphorylation
P-type ATPases are called as such, because of the formation
of a phosphorylated intermediate during the catalytic cycle. Fig.
5A depicts an SDS-PAGE electrophoretogram of the K+-
sensitive phosphorylated intermediate of human non-gastric H,
K-ATPase (lanes 2 and 3 without and with K+, respectively).
The presence of either SCH 28080 (lane 4) or oligomycin (lane
5) apparently increased the level of phosphorylated intermedi-
ate. Ouabain (lane 6) had no effect, whereas vanadate (lane 7)Fig. 4. The effects of ouabain (A), SCH 28080 (B) and oligomycin (C) on the AT
measured in the presence of 2.0 mMMgATP, 0.1 mM EGTA, 0.2 mM EDTA, 0.8 mM
(□), with either 10 mM KCl (○), or 100 mM NaCl (▴), or 10 mM NH4Cl (●) and t
choline chloride. All ATPase activities were corrected for those of mock-infected mem
h−1) without inhibitor was set at 100%.decreased the amount of phosphorylated intermediate but to a
lesser extent than K+.
The steady-state level of the phosphorylated intermediate
that is reached after 10 s in the absence of any added cation and
at pH 6.0 and 0 °C, increased with the ATP concentration up to
an apparently maximal value (Fig. 5B, open symbols).
Scatchard plot analysis of these mock-corrected phosphoryla-
tion values revealed a high apparent affinity for ATP
(Kd=40 nM), whereas extrapolation to infinite ATP concentra-
tions indicated a maximal phosphorylation level of 19.6±
4.0 pmol P mg−1 protein (Fig. 5C). These phosphorylation
experiments were carried out at the lowest possible protein
concentrations so that the endogenous K+ concentration was
minimal (≤1 μM). When the phosphorylation experiment was
carried out in the presence of 100 μM oligomycin the maximal
phosphorylation level markedly increased (31.2±6.4 pmol P
mg−1 protein), whereas the apparent affinity increased about 4
times to 10±1 nM (see Fig. 5B and C, closed symbols).Pase activity of HKα2-NaKβ1. ATPase activity of the membrane preparations
MgCl2, 1 mM TrisN3 and 50 mM Tris–acetate pH 7.0 in the absence of cations
he indicated inhibitor concentrations. The ionic strength was kept constant with
branes. The activity in the presence of 10 mMNH4Cl (42.2±9.0 μmol Pi. mg
−1.
Fig. 5. The ATP dependence of the ATP phosphorylation level of HKα2-NaKβ1. (A) SDS-PAGE electrophoretogram of phosphorylated membranes of mock-infected cells
(lane 1), and non-gastric H,K-ATPase (lanes 2 to 7) Phosphorylation was carried in the presence of either 10 mMKCl, 0.1 mM SCH 28080, 0.1 mM oligomycin, 1.0 mM
ouabain and 1.0 mM vanadate. SDS gel electrophoresis was carried out as described before [37]. (B) Steady-state phosphorylation levels of HKα2-NaKβ1. Membranes of
HKα2-NaKβ1 were treated with (●) and without (○) 100 μM oligomycin for 30 min at 0 °C after which they were incubated in the presence of the indicated ATP
concentrations and 0.1 mM EGTA, 0.2 mM EDTA, 1.3 mM MgCl2, 1 mM TrisN3 and 50 mM Tris–acetate pH 6.0 for another 10 s. The phosphorylation level was
determined as described under Materials and methods and corrected for the activity of mock-infected cells. (C) Scatchard plot of the data from panel B. Control: Kd
apparent=0.04±0.004 μM, E-Pmax=19.6±4.0 pmol P. mg
−1 protein. With oligomycin: Kd apparent=0.01±0.001 μM, E-Pmax=31.2±6.4 pmol P. mg
−1 protein.
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tion level decreased with increasing pH value (Fig. 6). A 10-fold
decrease was observed when going from pH 6.0 to pH 8.0. This
is in agreement with a stimulatory effect of H+ on the
phosphorylation reaction. At pH 6.0, Na+ dose-dependently
decreased the steady-state phosphorylation level to about half
the initial value. At pH 7.0, however, this cation decreased the
steady-state phosphorylation level down to zero. The very low
level at pH 8.0 was only slightly further decreased at Na+
concentrations beyond 100 mM. Na+ never enhanced the
steady-state phosphorylation level even not at pH 8.0,
demonstrating that this cation does not stimulate the phosphor-
ylation reaction. This was neither the case when the steady-state
phosphorylation level was determined in the presence of
oligomycin both at pH 6.0 and pH 8.0 (not shown).
When measured at pH 6.0 and 22 °C, the steady-state
phosphorylation level was dose-dependently increased by SCH
28080 (Fig. 7A). This effect of the inhibitor was considerably
less when the reaction was carried out at 0 °C (not shown). The
observed increase can be explained by the fact that the
phosphorylation level obtained under these conditions was
significantly lower than the maximum attainable level. Ouabain
did not increase the steady-state phosphorylation level at either
0 °C (not shown) or 22 °C (Fig. 7B). Fig. 7C shows that
ouabain did also not alter the phosphorylation level when SCH28080 was already present at its optimal concentration
(100 μM).
The properties of the phosphorylated intermediate(s) gener-
ated in the absence (Fig. 8A) or presence of oligomycin (Fig.
8B) were tested by first phosphorylating the enzyme with or
without this inhibitor, followed by a 3 s chase in the absence or
presence of either 2 mM ADP or 1.0 mM K+. Fig. 8A shows
that in the control situation only 15±2% of the phosphorylated
intermediate was not hydrolyzed within 3 s of incubation in the
absence of any added cation. In the presence of oligomycin, this
value was slightly reduced to 28±2% (Fig. 8B). ADP somewhat
increased the dephosphorylation rate in the control situation, but
dramatically increased this rate in the oligomycin condition.
Conversely, K+ did not alter the dephosphorylation rate in the
oligomycin condition, whereas it stimulated the dephosphor-
ylation step in the control situation. These findings indicate that
the phosphorylated intermediate generated in the presence of
oligomycin is nearly completely in the E1-P conformation,
whereas the intermediate generated in its absence is partly in the
E1-P and partly in the E2-P form.
The cation specificity of the dephosphorylation reaction was
further studied in the absence of oligomycin (Fig. 9). All three
cations used in this study dose-dependently increased the
dephosphorylation rate but the apparent affinity for Na+ (Fig.
9C) was much lower that that for K+ (Fig. 9A) and NH4
+ (Fig. 9B).
Fig. 8. The effect of K+ and ADP on the apparent dephosphorylation rates of
phosphorylated intermediates of HKα2-NaKβ1 generated in the absence
(panel A) and presence of oligomycin (panel B). The membranes of HKα2-
NaKβ1 were incubated with 0.1 μM ATP, 0.1 mM EGTA, 0.2 mM EDTA,
1.3 mM MgCl2, 1 mM TrisN3 and 50 mM Tris–Acetate pH 6.0 without
further addition (panel A), or 100 μM oligomycin (panel B) for 10 s at
0 °C. Next, the mixture was 8.3 times diluted with 1 mM non-radioactive
ATP without (○) and with either 1 mM KCl (●) or 2 mM ADP (□) after
which the incubation was continued for another 3 s. The residual phos-
phorylation level corrected for that of mock-infected cell membranes was
expressed as percentage of the level at t=0. The 100% values were: no
addition: 15.6±2.1 pmol. mg−1 protein; oligomycin: 37.6±1.1 pmol. mg−1
protein.
Fig. 6. The effect of NaCl on the steady-state ATP phosphorylation level of
HKα2-NaKβ1. The membranes of HKα2-NaKβ1 were incubated with 0.1 μM
ATP, 0.1 mM EGTA, 0.2 mM EDTA, 1.3 mMMgCl2, 1 mM TrisN3 and 50 mM
Tris–Acetate pH 6.0 (■), pH 7.0 (○) or pH 8.0 (●) and the indicated NaCl
concentrations for 10 s at 0 °C. Data were corrected for those of mock-infected
cell membranes. and the phosphorylation level in the absence of added cation at
pH 6.0 (19.7±3.1 pmol mg−1 protein) was set at 100%.
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accompanying subunit. In order to exclude the possibility that
the difference in cation sensitivities between the human and the
rat non-gastric H,K-ATPase could be attributed to the use of two
different species in the human study, we carried out some
experiments with the human β1-subunit. The cation dependence
of the latter preparation was similar to that of the preparation
with the rat β1-subunit as shown in Fig 2A. The sensitivity for
inhibitors, like vanadate, oligomycin, ouabain and SCH 28080
was also hardly changed (not shown).
4. Discussion
In this study, we investigated the enzymatic properties of the
human non-gastric H,K-ATPase following functional expres-
sion together with the β1 subunit of Na,K-ATPase in Sf9 cells.Fig. 7. Effects of SCH 28080 and ouabain on the steady-state phosphorylation levels
ATP, 0.1 mM EGTA, 0.2 mM EDTA, 1.3 mMMgCl2, 1 mM TrisN3 and 50 mM Tris
concentrations for 10 s at 22 °C. Data given as means with SEM for 3 experimentsThe presence of this particular β subunit was absolutely
required because a 50 times lower activity was obtained in
combination with the β-subunit of gastric H,K-ATPase,
whereas the combination with the β3-subunit of Na,K-ATPase
showed no activity at all. Therefore, the latter two β-subunits
were not included in the remainder of this study.
This study was carried out with the rat β1-subunit, which
excludes the possibility that kinetic differences between human
and rat can be attributed to the species of the β1-subunit.of HKα2-NaKβ1. The membranes of HKα2-NaKβ1 were incubated with 0.1 μM
–Acetate pH 6.0 and the indicated SCH 28080 (A and C) and ouabain (B and C)
were corrected for those of mock-infected cells.
Fig. 9. The effect of cations on the dephosphorylation of phosphorylated intermediates of HKα2-NaKβ1. The membranes of HKα2-NaKβ1 were incubated at 0 °C for
10 s with 0.1 μM ATP, 0.1 mM EGTA, 0.2 mM EDTA, 1.3 mM MgCl2, 1 mM TrisN3 and 50 mM Tris–acetate pH 6.0. Next, the mixture was 8.3 times diluted with
1 mM non-radioactive ATP and the indicated KCl (A), NH4Cl (B) or NaCl (C) concentrations and the incubation was continued for 3 s. The residual phosphorylation
level corrected for that of mock-infected cell membranes was expressed as percentage of the level at t=0 (100%=23.8±6.4 pmol. mg−1 protein).
Fig. 10. Post-Albers reaction scheme for H,K-type ATPases. The simplified
scheme includes the site of vanadate and oligomycin inhibition.
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subunit suggest that the species of the β1-subunit is not
important for the findings of this study.
The majority of the rat β1-subunit was glycosylated and
inhibition of the glycosylation process with tunicamycin
revealed that, as with the gastric H,K-ATPase [32], glycosyla-
tion is essential for cation activation of human non-gastric H,K-
ATPase. This is in sharp contrast with the situation in Na,K-
ATPase, the normal partner of the β1-subunit, where prevention
of glycosylation by mutation of all three asparagines into
glutamine did not impede the catalytic activity of the enzyme
[33].
The present study yielded several surprising results. In the
first place, we found that the activity of human non-gastric H,K-
ATPase could well be stimulated by NH4
+ but hardly by K+ (Fig.
2A). Because the enzyme fully obeys the Post-Albers reaction
scheme and both ions stimulated the dephosphorylation reaction
with similar affinity (Fig. 9), this finding most likely indicates
that K+ has a much stronger E2-promoting effect than NH4
+. This
idea was substantiated by the observation that considerably
more ATP was needed for activation of the enzyme by K+ than
for its activation by NH4
+ (Fig. 3A). ATP promotes the E2 to E1
conversion (step 1 in Fig. 10) and this reaction is counteracted
by cations that stimulate step 5 in the opposite direction. In
addition, we found that high Na+ concentrations could increase
the activity of human non-gastric H,K-ATPase to a level that
approached the maximal level obtained with NH4
+. In agreement
with this result, Na+ was found to stimulate the depho-
sphorylation reaction of this enzyme and to have a strong E1-
promoting effect. Thus, in contrast to K+, Na+ does not slow
down the E2 to E1 conversion (Fig. 10). Compared to the rat
enzyme, the stimulatory effects of Na+ and K+ on the activity of
the human enzyme are much larger and smaller, respectively
[5].
A second surprising result was that Na+ could not increase
the steady-state phosphorylation level, even not at pH 8.0 wherethis level is very low in the absence of this cation. This finding
indicates that Na+ is an agonist for K+ and NH4
+ and not an
agonist for H+. A similar conclusion was reached before with
the non-gastric [5] and gastric H,K-ATPase [27] of the rat. Thus,
our findings do not support the idea that non-gastric H,K-
ATPase transports Na+ along with H+ out of the cell [12,13].
Thirdly, this study shows that the human non-gastric H,K-
ATPase is moderately sensitive to ouabain. Sensitivity was
highest for the Na+-activated enzyme, less high for the NH4
+-
activated enzyme and absent for the K+-stimulated enzyme.
This is in agreement with the well-known antagonistic effect of
K+ on ouabain binding to Na,K-ATPase.
In the fourth place, the human enzyme appeared moderately
sensitive to SCH 28080, whereas the rat enzyme was shown by
us before to be virtually insensitive to this inhibitor (Table 1).
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less with NH4
+ and almost absent with K+. Also in this case, the
antagonism between K+ and SCH 28080 binding might explain
this difference.
Interestingly, we found that SCH 28080 could increase the
steady-state phosphorylation level of human non-gastric H,K-
ATPase (Fig. 7A). A similar finding was previously made with
rat gastric H,K-ATPase and explained by a stabilizing effect of
SCH 28080 on the phosphorylated intermediate [30]. Most
likely this explanation holds also for human non-gastric H,K-
ATPase. SCH 28080 did not increase the phosphorylation level
of rat non-gastric H,K-ATPase, which is in agreement with its
lower affinity for this inhibitor (not shown). The present finding
that the stabilizing effect of SCH 28080 was less pregnant at
0 °C, probably points to differences in temperature sensitivity of
the partial reactions. Surprisingly, no increase in phosphoryla-
tion level was found with ouabain (Fig. 7B). We previously
reported that ouabain readily increased the phosphorylation
level of a chimera between rat gastric H,K-ATPase and Na,K-
ATPase [31]. Therefore, we assume that ouabain, in contrast to
SCH 28080, is unable to stabilize the phosphorylated
intermediate of the human non-gastric H,K-ATPase.
In some other aspects the human non gastric H,K-ATPase
behaved rather similar to the rat enzyme. Oligomycin approxi-
mately doubled the phosphorylation level and the phosphory-
lated intermediate in the presence of this drug became ADP-
sensitive and lost its K+-sensitivity. This indicates that as in Na,
K-ATPase and rat non-gastric H,K-ATPase oligomycin inhibits
the E1P to E2P conversion (reaction 3 in Fig. 10).From the
maximal NH4
+-stimulated ATPase activity and the phosphoryla-
tion level measured in the presence of oligomycin a turnover
number of 21,900±4600 min−1 could be calculated. This value
was not significantly different from that calculated for rat non-
gastric H,K-ATPase [5], despite the fact that the absolute ATPase
activity of the expressed human enzymewas about twice as high.
As far as we know, it is the highest P-type ATPase activity ever
measured in an expression system.
Table 1 summarizes the differences and similarities between
the expressed human and rat enzymes as carried out in our
laboratory. It is clear that the differences are mainly in the
sensitivities for cations and drugs. The differences cannot be
attributed to the β-subunit since in both preparations the β1
subunit of rat Na,K-ATPase was used. Why are the properties of
both enzymes so different? At the amino acid level the
similarity between the human and rat enzyme is 86%, which
is relatively low as compared to the species differences
observed for Na,K- and gastric H,K-ATPase. The lowest
similarity (50%) is present in the region encompassing the
first 60 N-terminal amino acids. In agreement with the nature of
the differences between human and rat non-gastric H,K-
ATPase, this region was found to play an important role in
regulating the E1/E2 equilibrium in Na,K-ATPase [34].
Transmembrane segments play an important role in both cation
and drug binding. Within the ten putative transmembrane
segments, 27 out of 200 amino acids are different, which is quite
normal for subunits of this subfamily of ATPases. Strikingly,
there are only two and three conservative differences in M4 andM5, respectively, whereas the amino acids in M6 are completely
similar. None of the residues found to be crucial for cation
binding in Na,K-ATPase and gastric H,K-ATPase differs
between the human and rat non-gastric H,K-ATPase. This
means that the observed differences in ion sensitivities between
these two species must be due to subtle differences in amino
acid composition that play a role in the hydrogen bond network
around the ion binding sites and/or in residues involved in the
access pathways to these binding sites.
Vagin et al. [35] postulated a model for the binding site of
SCH 28080 on gastric H,K-ATPase. In their model the surface
between Leu809 in the M5-M6 loop and Cys813 in the luminal
end of M6 are implicated in SCH 28080 binding. In addition,
residues on M8 play a role in SCH 28080 binding. As stated
before, none of the residues in M6 are different between human
and rat non-gastric H,K-ATPase. On the other hand, there are
four differences between human and rat inM8. However, all four
are rather far away from the postulated SCH 28080 binding site.
There are also indications that Met334 and Val337 (corresponding
to Ile325 an Ile328 in the rat non gastric H,K-ATPase) in M4 are
involved in SCH 28080 binding [36]. It is very well possible that
the Gly/Ser difference between human and rat in residue 326
causes the lower SCH 28080 affinity of the rat enzyme. Taken
together, on basis of the present knowledge it is impossible to
attribute the differences in cation and drug sensitivities between
human and rat to specific residues.
What do these studies tell us about the physiological role of
non-gastric H,K-ATPase in man? In rat it has been shown that
after a hypokalemic diet this enzyme is upregulated in the
kidney [3,8,9]. This has led to the conclusion that the primary
role of this enzyme is in K+ reuptake by the kidney. For the rat
enzyme, we have reported that the maximum activity with NH4
+
is much higher than with K+ [5]. In human this difference is
even higher. Studies with hypokalemia are nearly impossible to
carry out with humans. It is therefore not sure whether also in
man this condition results in an upregulation of non-gastric H,
K-ATPase. The apical localization of this enzyme together with
the present finding that Na+ cannot replace H+ as activating
cation, suggests a role of this enzyme in apical H+/ NH4
+
exchange. Such an electroneutral transport would not contribute
to pH regulation, but only to prevention of a too large loss of
NH4
+. It is also possible that under certain circumstances
the enzyme might function as a H+/Na+ exchanger given the
high ATPase activity that can be obtained with high Na+
concentrations.
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